Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 156 The United Laboratories International Holdings Limited Annual Report 2022 45. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (a) Statement of financial position of the Company 2022 2021 RMB’000 RMB’000 Non-current assets Interests in subsidiaries 4,260,026 4,010,531 Right-of-use assets 3,856 – Property, plant and equipment 82 424 4,263,964 4,010,955 Current assets Other receivables and prepayments 2,831 2,726 Amounts due from subsidiaries 2,706,364 641,854 Derivative financial instruments 1,841 – Cash and cash equivalents 690,361 982,764 3,401,397 1,627,344 Current liabilities Other payables and accrued charges 10,616 4,704 Amount due to a subsidiary 228,038 150 Borrowings – due within one year 1,107,980 1,530,345 Derivative financial instrument 10,087 5,812 Lease liabilities 806 – Tax payable 564 1 1,358,091 1,541,012 Net current assets 2,043,306 86,332 Total assets less current liabilities 6,307,270 4,097,287 Non-current liabilities Borrowings – due after one year 1,095,789 – Lease liabilities 3,071 – 1,098,860 – Net assets 5,208,410 4,097,287 Capital and reserves Share capital 16,965 17,125 Reserves 5,191,445 4,080,162 Total equity 5,208,410 4,097,287